| Typicality: | 0.320 |
| Saliency: | 0.164 |
| vaccine → be developed by → pharmaceutical company | 4 |
| vaccine → be developed by → british pharmaceutical company | 3 |
| vaccine → be developed by → company | 3 |
| negative | neutral | positive |
| 0.066 | 0.638 | 0.296 |
| Raw frequency | 10 |
| Normalized frequency | 0.164 |
| Modifier score | 0.500 |
| Perplexity | 80.067 |